COVID-19 and disease-modifying therapies in patients with demyelinating diseases of the central nervous system: A systematic review

INTRODUCTION: The Coronavirus disease-19 (COVID-19) pandemic continues to expand across the world. This pandemic has had a significant impact on patients with chronic diseases. Among patients with demyelinating diseases of the central nervous system (CNS), such as Multiple Sclerosis (MS) or Neuromye...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharifian-Dorche, Maryam, Sahraian, Mohammad Ali, Fadda, Giulia, Osherov, Michael, Sharifian-Dorche, Amirhossein, Karaminia, Maryam, Saveriano, Alexander William, La Piana, Roberta, Antel, Jack P, Giacomini, Paul Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7845520/
https://www.ncbi.nlm.nih.gov/pubmed/33578206
http://dx.doi.org/10.1016/j.msard.2021.102800

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7845520/
https://www.ncbi.nlm.nih.gov/pubmed/33578206
http://dx.doi.org/10.1016/j.msard.2021.102800

Ejemplares similares